Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism nAChRα4&β2 agonists(Neuronal acetylcholine receptor; alpha4/beta2 agonists), α3β4 receptor agonists(Neuronal acetylcholine receptor; alpha3/beta4 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H15FN2O |
InChIKeyCYQKWJWBZBKTDK-INIZCTEOSA-N |
CAS Registry1434047-64-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tobacco Use Disorder | Preclinical | - | - | |
Tobacco Use Disorder | Preclinical | - | - |